Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Influenza Hemagglutinin (HA) Peptide: Precision Tag for P...

    2026-01-13

    Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Detection and Purification

    Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic epitope tag derived from the human influenza virus hemagglutinin protein, and is widely used for tagging, detection, and purification of recombinant proteins in molecular biology research. HA tag peptides like APExBIO’s A6004 exhibit >98% purity by HPLC/mass spectrometry and are highly soluble in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL) under standard laboratory conditions (product documentation). The HA tag enables the competitive elution of HA fusion proteins from Anti-HA antibody-based immunoprecipitation assays, facilitating reproducible protein interaction studies (Dong et al., 2025). Reliable performance requires storage at –20°C in a desiccated state, as aqueous solutions are not recommended for long-term storage. This article clarifies the mechanism, evidence, and best practices for deploying the HA peptide tag in modern molecular workflows.

    Biological Rationale

    The HA tag sequence (YPYDVPDYA) is derived from the influenza virus hemagglutinin protein, specifically from a highly immunogenic epitope region recognized by monoclonal Anti-HA antibodies (Dong et al., 2025). This minimal, 9-amino acid peptide is genetically fused to recombinant proteins of interest, enabling their immunological detection and affinity purification. The small size minimizes structural interference and preserves the function of fusion partners in most applications.

    Epitope tagging using peptides such as the HA tag is foundational in protein biochemistry. It facilitates the study of protein localization, interaction, and post-translational modifications in both in vitro and in vivo systems (see related protocol guide). Unlike large affinity tags, the HA peptide rarely disrupts protein folding or function, making it suitable for a wide range of applications, including co-immunoprecipitation, pull-downs, and competitive elution assays.

    Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

    The HA peptide tag functions as an epitope that is specifically recognized by Anti-HA monoclonal antibodies (e.g., clone 12CA5 or HA.11). When fused to a target protein, the tag enables immunoprecipitation or detection by these antibodies. In elution workflows, free HA peptide is added in excess to compete with bound HA-tagged proteins for antibody binding sites, triggering their release from antibody-conjugated beads or matrices (Dong et al., 2025).

    The competitive binding mechanism is reliable due to the high affinity and specificity of Anti-HA antibodies for the YPYDVPDYA sequence. This process is reversible and does not require harsh elution conditions, preserving native protein complexes for downstream analysis. The HA tag’s compatibility with both magnetic and agarose bead platforms extends its utility across diverse workflows (see assay applications).

    Evidence & Benchmarks

    • APExBIO’s Influenza Hemagglutinin (HA) Peptide (A6004) is validated to >98% purity by HPLC and mass spectrometry (product page).
    • The HA tag (YPYDVPDYA) enables efficient competitive elution of fusion proteins in immunoprecipitation assays using Anti-HA antibodies, with recovery rates exceeding 80% under standard conditions (Dong et al., Table S1, DOI).
    • Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at room temperature (20–25°C) (product documentation).
    • HA-tagged proteins can be detected at sub-nanogram levels by Anti-HA antibodies in standard Western blot protocols (protocol resource).
    • HA peptide-based competitive elution preserves protein–protein interactions, enabling downstream mass spectrometry and signaling studies (Dong et al., 2025).

    Applications, Limits & Misconceptions

    The Influenza Hemagglutinin (HA) Peptide is a versatile tag for protein detection, purification, and interaction mapping. Its applications encompass:

    • Immunoprecipitation (IP) and co-immunoprecipitation (co-IP) assays for protein–protein interaction analysis.
    • Affinity purification of HA-tagged fusion proteins via Anti-HA magnetic or agarose beads.
    • Competitive elution of proteins under native conditions, preserving functional complexes (see troubleshooting guide—this article extends evidence by including new purity data and workflow parameters).
    • Western blotting and immunofluorescence for tagged protein detection.
    • Protein localization and quantification in cellular systems.

    Common Pitfalls or Misconceptions

    • The HA tag does not confer intrinsic affinity for non-HA antibodies or generic resins—use only validated Anti-HA reagents.
    • Overexpression of HA-tagged proteins may result in aggregation or non-specific interactions; titrate expression levels as needed.
    • The HA peptide sequence cannot substitute for larger affinity tags (e.g., His6, FLAG) in metal-chelate chromatography.
    • Long-term storage of HA peptide in solution (>1 week) at 4°C or room temperature leads to degradation—store desiccated at –20°C.
    • Cross-reactivity with endogenous influenza proteins is possible in infected or vaccinated samples—validate backgrounds in controls.

    Workflow Integration & Parameters

    APExBIO’s Influenza Hemagglutinin (HA) Peptide (A6004) is supplied at >98% purity, enabling direct use in immunoprecipitation and competitive elution protocols (A6004 kit). Recommended working concentrations for competitive elution range from 0.5 to 2 mg/mL, depending on the bead type and volume. The peptide is compatible with common biological buffers (PBS, TBS) and can be dissolved directly in DMSO, ethanol, or water. For optimal activity, freshly prepare peptide solutions and avoid freeze-thaw cycles.

    Integration into multiplexed or automated workflows is straightforward due to the tag’s minimal size and lack of post-translational modifications. The HA tag is compatible with both N- and C-terminal fusion strategies, but steric effects should be empirically validated for each construct. For advanced use-cases—such as mapping ubiquitination or studying metastasis signaling—review detailed protocol extensions and troubleshooting approaches in this translational research guide, which this article updates by providing new solubility and stability data.

    Conclusion & Outlook

    The Influenza Hemagglutinin (HA) Peptide (APExBIO A6004) is a gold-standard tool for epitope tagging, detection, and purification in molecular biology. Its high purity, benchmarked solubility, and compatibility with competitive elution protocols make it a reliable choice for sensitive protein-protein interaction and signaling studies. Proper storage and validated anti-HA reagents are essential for optimal results. As workflows evolve toward greater throughput and mechanistic resolution, the HA tag remains an indispensable standard for precision molecular research. For further technical details and ordering information, consult the Influenza Hemagglutinin (HA) Peptide product page.